ACCESS BIO
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · New Jersey, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
65 Clyde Rd Ste A, Somerset, New Jersey,...Phone Number
(732) 873-4040Website
www.accessbio.netRevenue
$73.4 MillionStock Symbol
950130Industry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
2
1
1
1
1
About ACCESS BIO
Access Bio (KOSDAQ: 950130) is dedicated to the prevention and early diagnosis of infectious diseases through research, development, and manufacturing of in vitro rapid diagnostic tests, biosensors, and molecular diagnostic products. The company's in vitro diagnostic test platform includes immunochemical, biochemical, and molecular products. Headquartered in Somerset, New Jersey, Access Bio serves its global customer base from manufacturing sites located in the U.S., Ethiopia, and South Korea. In 2018 the company reported $36.6 million of revenues, largely from sales of its industry-leading malaria RDT products. The company has commercially launched a number of additional diagnostic tests that leverage its industry-leading expertise and manufacturing capacity.Explore more
ACCESS BIO Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ACCESS BIO your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if ACCESS BIO is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
ACCESS BIO, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if ACCESS BIO had a recent Job posting/layoffs
Product Launch: Get notified when ACCESS BIO launches new products
Check if ACCESS BIO has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once ACCESS BIO has new funding data
Earning: See what the market has to say on ACCESS BIO recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at ACCESS BIO
Recommended Actions
Reach out to Masked Content who joined ACCESS BIO as Masked Content
Find more new buyers
Compare Similar Companies to ACCESS BIO
Compare insights from companies similar to ACCESS BIO, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
ACCESS BIO is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
ACCESS BIO is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about ACCESS BIO.
ACCESS BIO Tech Stack
A closer look at the technologies used by ACCESS BIO
See more technologies
Most Recent Scoops
Project
, according to a mid-level source in logistics, is planning to begin initiatives related to inventory control and management within three months. ACCESS BIO will be increasing funding to support these efforts. The organization is planning to leverage an internally developed enterprise resource planning (ERP) system in this area.
Spending/Investment, Financial Planning, Funding, Enterprise Software, Software, Logistics / Supply Chain, Inventory Management, Enterprise Resource Planning, Finance
Pain Point
, according to a mid-level source in logistics, is experiencing challenges related to last mile delivery software.
Pain Point, Software, Logistics / Supply Chain
Project
, according to a mid-level source in logistics, is planning to begin initiatives related to distribution software within three months. ACCESS BIO will be increasing funding to support these efforts. The organization is planning to leverage an internally developed enterprise resource planning (ERP) system in this area.
Spending/Investment, Financial Planning, Funding, Enterprise Software, Software, Logistics / Supply Chain, Enterprise Resource Planning, Finance
Pain Point
, according to a mid-level source in logistics, is experiencing challenges related to direct store delivery software.
Pain Point, Retail/Store Systems, Software, Logistics / Supply Chain
Pain Point
Pain Point, Software, Capacity Planning, Logistics / Supply Chain, Enterprise Resource Planning
ACCESS BIO News & Media
ADG and Maddox Defense Partner with Access Bio to Deliver US-Made COVID Test Kits to Defense Logistics Agency
New Contract Bolsters the US Supply Chain for Pandemic Response New Contract Bolsters the US Supply Chain for Pandemic ResponseAirBoss Defense Group and Maddox Defense Partner With Access Bio to Deliver US-Made COVID Test Kits to Defense Logistics Agency
NEWMARKET, Ontario, Dec. 28, 2022 (GLOBE NEWSWIRE) -- AirBoss of America Corp. (TSX: BOS)(OTCQX:ABSSF) (the “Company” or “AirBoss”) today announced that the Defense Logistics Agency (“DLA”) has awarded an Indefinite Delivery/Indefinite Quantity (IDIQ) contract valued at up to US$410M to Access Bio, an industry leader in medical testing and diagnostics, supported by a U.S. coalition including AirBoss Defense Group (“ADG”), Maddox Defense, and a network of US test kit component suppliers. This comHochul says she had no role in New York's $637M deal with campaign donor
Gov. Kathy Hochul says that before her staff inked $637 million in purchase orders with a major campaign donor, Hochul was never asked to give final approval to the massive taxpayer-funded deals.Intrivo CEO on how medtech startups can band together to help Ukraine: 'This is a call to action'
COVID-19 diagnostic developer Intrivo recently donated more tha | “There’s a lot of power in a lot of people coming together to do tiny little things that add up to something really big," Intrivo CEO Ron Gutman told Fierce Medtech.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ACCESS BIO
Sign Up For FreeTo access detailed company insights
Access Bio (KOSDAQ: 950130) is dedicated to the prevention and early diagnosis of infectious diseases through research, development, and manufacturing of in vitro rapid diagnostic tests, biosensors, and molecular diagnostic products. The company's in vitro diagnostic test platform includes immunochemical, biochemical, and molecular products. Headqu... Read More
